Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Lee, Agnes; N. Levine, Mark; Baker, Ross; Bowden, Chris; K. Kakkar, Ajay; H. Prins, Martin; R. Rickles, Frederick; A. Julian, Jim; L. Haley, Susan; J. Kovacs, Michael; Gent, Michael

doi:10.1056/nejmoa025313

Public

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Published in New England Journal of Medicine • Jul 9, 2003

Authors:

Agnes Lee

Mark N. Levine

Ross Baker

Abstract

BACKGROUND: Patients with cancer have a substantial risk of recurrent thrombosis despite the use of oral anticoagulant therapy. We compared the efficacy of a low-molecular-weight heparin with that of an oral anticoagulant agent in preventing recurrent thrombosis in patients with cancer. METHODS: Pat...

Subject

Medicine

Anticoagulant

Low molecular weight heparin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!